S. Korea prosecutors seek 25 years for ex-president's friend
6,700 Rohingya killed in first month of Myanmar violence: MSF
Casualties as bomber attacks Somalia police academy: officer
Ecuador's VP handed 6 years in prison in Odebrecht graft case
Dow ends at record on tax bill progress, Fed outlook
US-led air strikes kill 23 civilians in Syria: monitor
Fed's Yellen says no risks to stability 'flashing red' as markets boom
May loses key Brexit vote in British parliament
US Fed raises key interest rate amid strong labor market
Austrian airline Niki says to stop flying Thursday
Netanyahu 'not impressed' by Muslim leaders' Jerusalem statements
Paris suspect Abdeslam's lawyer asks for Belgian trial to be postponed: source
Erdogan accuses Trump of 'Zionist mentality' over Jerusalem recognition
S.Arabia, UAE pledge $130 mn for Sahel anti-terror force
Energy costs push US consumer inflation above Fed target to 2.2%
Muslim leaders urge recognition of East Jerusalem as Palestine capital: statement
EU Parliament backs opening next round of Brexit talks: president
Palestinians have right to east Jerusalem as capital: Saudi king
Kremlin welcomes 'constructive' US position on N. Korea talks
Abbas warns 'no peace or stability' without Jerusalem as Palestinian capital
Erdogan urges world to recognise East Jerusalem as 'capital of Palestine'
Strikes kill 12 in rebel-run Yemen prison camp: rebel TV
Israel a state of 'occupation' and 'terror', Erdogan tells Islamic leaders
Alabama Democrat Jones projected to win US Senate race
UN envoy says North Korea agrees on need 'to prevent war'
Kim vows to make N.Korea 'world's strongest nuclear power': KCNA
US ready for North Korea talks 'without preconditions'
Dow, S&P 500 end at records as banking shares gain
Brazil court to rule on Lula jail sentence Jan 24
Liberia presidential runoff set for Dec 26: election panel
Venezuela's ex-oil boss under investigation for graft
'We're losing the battle', Macron tells Paris climate talks
With fossil fuel subsidies, humanity investing in 'own doom': UN chief
Russia suspends diplomatic presence in Yemen
Ireland-based Ryanair pilots to strike on December 20
Stoltenberg reappointed as NATO chief until 2020: statement
World Bank to stop financing oil, gas projects from 2019
Two Palestinians killed in Gaza, Israel denies claim of attack
S.Sudan clashes leave more than 170 dead: lawmaker
Macron calls for 'much stronger mobilisation' on climate
EU pulls support for Cambodia poll after opposition dissolved
Magnitude 6.2 quake hits southeastern Iran: seismological centre
Explosion at major Austrian gas hub, 'several' hurt
France's Unibail-Rodamco to buy Australia's Westfield: statement
Trump wants Congress to fix 'lax' immigration after NY attack
ANZ Bank sells life insurance arm to Zurich for US$2.14 bn
Trump tells NASA to send Americans to Moon
Apple to buy song recognition app Shazam
Brexit deal shows UK can leave EU in 'smooth and orderly' way: May
China fails to block UN meeting on North Korea human rights
Four hurt in New York explosion, none life-threatening
Man held over jihadist murders of French police couple
Putin calls for Mideast talks to resume, including on Jerusalem
'The Shape of Water' leads Golden Globe nominations with seven
Cairo, Moscow sign contract for Egypt's first nuclear plant
Police responding to explosion of 'unknown origin' in Manhattan
Putin orders partial withdrawal of Russian troops from Syria: agencies
India's Congress party names Rahul Gandhi president
Putin in surprise visit to Russia's airbase in Syria
Saudi Arabia lifts ban on cinemas: government
Recognising Jerusalem as Israel's capital 'makes peace possible': Netanyahu
EU's Mogherini condemns 'all attacks on Jews everywhere'
Bitcoin makes stock exchange debut at $15,000 Bitcoin makes debut on major stock exchange at $15,000 per unit Bitcoin makes debut on major stock exchange at $15,000 per unit
S. Korea prosecutors seek 25 years for ex-president's friend
6,700 Rohingya killed in first month of Myanmar violence: MSF
Casualties as bomber attacks Somalia police academy: officer
Ecuador's VP handed 6 years in prison in Odebrecht graft case
Dow ends at record on tax bill progress, Fed outlook
US-led air strikes kill 23 civilians in Syria: monitor
Fed's Yellen says no risks to stability 'flashing red' as markets boom
May loses key Brexit vote in British parliament
US Fed raises key interest rate amid strong labor market
Austrian airline Niki says to stop flying Thursday
Netanyahu 'not impressed' by Muslim leaders' Jerusalem statements
Paris suspect Abdeslam's lawyer asks for Belgian trial to be postponed: source
Erdogan accuses Trump of 'Zionist mentality' over Jerusalem recognition
S.Arabia, UAE pledge $130 mn for Sahel anti-terror force
Energy costs push US consumer inflation above Fed target to 2.2%
Muslim leaders urge recognition of East Jerusalem as Palestine capital: statement
EU Parliament backs opening next round of Brexit talks: president
Palestinians have right to east Jerusalem as capital: Saudi king
Kremlin welcomes 'constructive' US position on N. Korea talks
Abbas warns 'no peace or stability' without Jerusalem as Palestinian capital
Erdogan urges world to recognise East Jerusalem as 'capital of Palestine'
Strikes kill 12 in rebel-run Yemen prison camp: rebel TV
Israel a state of 'occupation' and 'terror', Erdogan tells Islamic leaders
Alabama Democrat Jones projected to win US Senate race
UN envoy says North Korea agrees on need 'to prevent war'
Kim vows to make N.Korea 'world's strongest nuclear power': KCNA
US ready for North Korea talks 'without preconditions'
Dow, S&P 500 end at records as banking shares gain
Brazil court to rule on Lula jail sentence Jan 24
Liberia presidential runoff set for Dec 26: election panel
Venezuela's ex-oil boss under investigation for graft
'We're losing the battle', Macron tells Paris climate talks
With fossil fuel subsidies, humanity investing in 'own doom': UN chief
Russia suspends diplomatic presence in Yemen
Ireland-based Ryanair pilots to strike on December 20
Stoltenberg reappointed as NATO chief until 2020: statement
World Bank to stop financing oil, gas projects from 2019
Two Palestinians killed in Gaza, Israel denies claim of attack
S.Sudan clashes leave more than 170 dead: lawmaker
Macron calls for 'much stronger mobilisation' on climate
EU pulls support for Cambodia poll after opposition dissolved
Magnitude 6.2 quake hits southeastern Iran: seismological centre
Explosion at major Austrian gas hub, 'several' hurt
France's Unibail-Rodamco to buy Australia's Westfield: statement
Trump wants Congress to fix 'lax' immigration after NY attack
ANZ Bank sells life insurance arm to Zurich for US$2.14 bn
Trump tells NASA to send Americans to Moon
Apple to buy song recognition app Shazam
Brexit deal shows UK can leave EU in 'smooth and orderly' way: May
China fails to block UN meeting on North Korea human rights
Four hurt in New York explosion, none life-threatening
Man held over jihadist murders of French police couple
Putin calls for Mideast talks to resume, including on Jerusalem
'The Shape of Water' leads Golden Globe nominations with seven
Cairo, Moscow sign contract for Egypt's first nuclear plant
Police responding to explosion of 'unknown origin' in Manhattan
Putin orders partial withdrawal of Russian troops from Syria: agencies
India's Congress party names Rahul Gandhi president
Putin in surprise visit to Russia's airbase in Syria
Saudi Arabia lifts ban on cinemas: government
Recognising Jerusalem as Israel's capital 'makes peace possible': Netanyahu
EU's Mogherini condemns 'all attacks on Jews everywhere'
Bitcoin makes stock exchange debut at $15,000 Bitcoin makes debut on major stock exchange at $15,000 per unit Bitcoin makes debut on major stock exchange at $15,000 per unit
Four-time Tour de France winner Chris Froome says he has not broken any rules after returning an "adverse" drugs test result during his victory at this year's Vuelta a Espana.
Froome had twice the permissible amount of asthma medication Salbutamol in his system during the Grand Tour race which he won in September, the UCI and his team revealed on Wednesday.
"I understand this comes as a big shock to people," Froome said in an interview with the BBC published late on Wednesday.
"I certainly haven't broken any rules here."
Cycling's governing body UCI said an anti-doping test on September 7 showed more than the allowable level of Salbutamol which can be taken without needing a therapeutic use exemption (TUE).
The 32-year-old Froome told the BBC he simply upped his dosage on the advice of the team doctor after his asthma symptoms got worse.
"I have been a professional cyclist now, treating my symptoms and racing with asthma, for 10 years," said Froome.
"I know what those rules are, I know what those limits are and I have never been over those limits."
The UCI has asked Froome to provide more information but in line with World Anti-Doping Agency guidelines has not suspended him.
"I have got a very clear routine when I use my inhaler and how many times. I have given all that information to the UCI to help get to the bottom of it." He added the UCI was "absolutely right" to scrutinise the test results.
Team Sky said in a statement: "During the final week of the Vuelta, Chris experienced acute asthma symptoms. On the advice of the Team Sky doctor, he used an increased dosage of Salbutamol (still within the permissible doses) in the run-up to the 7 September urine test."
Sky said Froome had declared his use of the medication, adding: "The notification of the test finding does not mean that any rule has been broken."
The British rider, who also won Olympic time-trial bronze medals in 2012 and 2016, was notified of the test on September 20, the day he finished third in the world time-trial championship in Bergen, Norway.
He has not competed since, but recently announced his intention to try to win two of cycling's three biggest races, the Tour de France and the Giro d'Italia, in 2018.
- 'Not a great day for cycling' -
Unipublic, the company that runs the Vuelta, refused Wednesday to take a negative stance on Froome saying they were waiting for the UCI to finish their probe before deciding whether to take any action against their champion.
"Our position is one of extreme prudence, and it is our hope that the matter will be resolved swiftly," Unipublic said on Wednesday.
Froome won the Vuelta September 10, 2017 finishing 2min 15sec clear of Vicenzo Nibali, who was saddened by the news.
"It's not a great day for cycling and it's not a great day for him," said the Italian climber Nibali, who has won all three major cycling tours.
"If this positive test is confirmed it will not feel as if I climbed onto the highest step of the podium to be declared champion in Madrid," said the 2014 Tour de France winner.
Froome, widely considered the greatest Tour rider of his generation, is scheduled to race the Giro d'Italia in May 2018 ahead of defending his Tour de France title in July 2018.
Sky's aim for next year was to have Froome enter a clique of riders who held all three Grand Tour titles at the same time, and for him to clinch a record equalling fifth Tour de France after his victories in 2013, 2015, 2016 and 2017.
The test is bound to raise new questions about British cycling following the scandal surrounding Bradley Wiggins, who received TUEs to take a corticosteroid in 2011, 2012 and 2013, including before his 2012 Tour de France win.
Wiggins and Sky have repeatedly denied any wrongdoing, saying the drug was prescribed to treat a longstanding pollen allergy.
In 2008 Italian sprinter Alessandro Petacchi was given a 12-month ban and stripped of five stage wins in the 2007 Giro d'Italia despite having a TUE for Salbutamol, having also exceeded the limit.
Four-time Tour de France winner Chris Froome says he has not broken any rules after returning an "adverse" drugs test result during his victory at this year's Vuelta a Espana.
Froome had twice the permissible amount of asthma medication Salbutamol in his system during the Grand Tour race which he won in September, the UCI and his team revealed on Wednesday.
"I understand this comes as a big shock to people," Froome said in an interview with the BBC published late on Wednesday.
"I certainly haven't broken any rules here."
Cycling's governing body UCI said an anti-doping test on September 7 showed more than the allowable level of Salbutamol which can be taken without needing a therapeutic use exemption (TUE).
The 32-year-old Froome told the BBC he simply upped his dosage on the advice of the team doctor after his asthma symptoms got worse.
"I have been a professional cyclist now, treating my symptoms and racing with asthma, for 10 years," said Froome.
"I know what those rules are, I know what those limits are and I have never been over those limits."
The UCI has asked Froome to provide more information but in line with World Anti-Doping Agency guidelines has not suspended him.
"I have got a very clear routine when I use my inhaler and how many times. I have given all that information to the UCI to help get to the bottom of it." He added the UCI was "absolutely right" to scrutinise the test results.
Team Sky said in a statement: "During the final week of the Vuelta, Chris experienced acute asthma symptoms. On the advice of the Team Sky doctor, he used an increased dosage of Salbutamol (still within the permissible doses) in the run-up to the 7 September urine test."
Sky said Froome had declared his use of the medication, adding: "The notification of the test finding does not mean that any rule has been broken."
The British rider, who also won Olympic time-trial bronze medals in 2012 and 2016, was notified of the test on September 20, the day he finished third in the world time-trial championship in Bergen, Norway.
He has not competed since, but recently announced his intention to try to win two of cycling's three biggest races, the Tour de France and the Giro d'Italia, in 2018.
- 'Not a great day for cycling' -
Unipublic, the company that runs the Vuelta, refused Wednesday to take a negative stance on Froome saying they were waiting for the UCI to finish their probe before deciding whether to take any action against their champion.
"Our position is one of extreme prudence, and it is our hope that the matter will be resolved swiftly," Unipublic said on Wednesday.
Froome won the Vuelta September 10, 2017 finishing 2min 15sec clear of Vicenzo Nibali, who was saddened by the news.
"It's not a great day for cycling and it's not a great day for him," said the Italian climber Nibali, who has won all three major cycling tours.
"If this positive test is confirmed it will not feel as if I climbed onto the highest step of the podium to be declared champion in Madrid," said the 2014 Tour de France winner.
Froome, widely considered the greatest Tour rider of his generation, is scheduled to race the Giro d'Italia in May 2018 ahead of defending his Tour de France title in July 2018.
Sky's aim for next year was to have Froome enter a clique of riders who held all three Grand Tour titles at the same time, and for him to clinch a record equalling fifth Tour de France after his victories in 2013, 2015, 2016 and 2017.
The test is bound to raise new questions about British cycling following the scandal surrounding Bradley Wiggins, who received TUEs to take a corticosteroid in 2011, 2012 and 2013, including before his 2012 Tour de France win.
Wiggins and Sky have repeatedly denied any wrongdoing, saying the drug was prescribed to treat a longstanding pollen allergy.
In 2008 Italian sprinter Alessandro Petacchi was given a 12-month ban and stripped of five stage wins in the 2007 Giro d'Italia despite having a TUE for Salbutamol, having also exceeded the limit.
Four-time Tour de France winner Chris Froome says he has not broken any rules after returning an "adverse" drugs test result during his victory at this year's Vuelta a Espana.
Froome had twice the permissible amount of asthma medication Salbutamol in his system during the Grand Tour race which he won in September, the UCI and his team revealed on Wednesday.
14 Dec 2017The global network of Agence France Presse covers 151 countries
Find out moreIf you have news to share or a question, comment or suggestion, contact us via...
If you have news to share or a question, comment or suggestion, contact us via...